Margaret M. Redfield

Mar 25, 2024 | jamanetwork.com | Daniel Davies |Margaret M. Redfield |Christopher Scott

Key PointsQuestion  Which patients with heart failure and preserved ejection fraction (HFpEF) have an increased risk of transthyretin amyloid cardiomyopathy (ATTR-CM) warranting technetium Tc 99m pyrophosphate scintigraphy?

Jun 1, 2023 | jacc.org | Akshay S. Desai |Carolyn S.P. Lam |John McMurray |Margaret M. Redfield

JACC Journals › JACC: Heart Failure › Archives › Vol. 11 No. 6 AbstractAlthough patients with heart failure with preserved ejection fraction (HFpEF) (left ventricular ejection fraction ≥50%) comprise nearly half of those with chronic heart failure, evidence-based treatment options for this population have historically been limited.